{"title":"Agile by adaptive design: An algorithm for decentralized trials","authors":"K. Shuvo Bakar","doi":"10.1016/j.cct.2025.108169","DOIUrl":null,"url":null,"abstract":"<div><div>Decentralized Clinical Trials (DCTs) represent a significant advancement in clinical research, offering greater accessibility, flexibility, and participant engagement through the use of telemedicine, mobile health technologies, and remote data capture. However, the decentralized nature of data collection introduces challenges related to data reliability and variability, which are often inadequately addressed by conventional statistical methods at the design stage of the trial.</div><div>This study presents an agile Bayesian design framework tailored to the specific needs of DCTs, integrating adaptive data reliability directly into trial design and analysis. Our approach is based on Bayesian decision rules to guide interim sample size adjustments. By treating data reliability as a model parameter rather than an external factor, our method accounts for uncertainty and improves the robustness of power calculations.</div><div>Simulation studies demonstrate the effectiveness of this strategy. The proposed framework enables a flexible and agile approach to DCT design that can adapt to varying data quality conditions. This work offers a foundation for extending the proposed adaptive method to other trial contexts, including time-to-event endpoints, and supports the broader adoption of DCTs in real-world clinical research.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"160 ","pages":"Article 108169"},"PeriodicalIF":1.9000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425003635","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Decentralized Clinical Trials (DCTs) represent a significant advancement in clinical research, offering greater accessibility, flexibility, and participant engagement through the use of telemedicine, mobile health technologies, and remote data capture. However, the decentralized nature of data collection introduces challenges related to data reliability and variability, which are often inadequately addressed by conventional statistical methods at the design stage of the trial.
This study presents an agile Bayesian design framework tailored to the specific needs of DCTs, integrating adaptive data reliability directly into trial design and analysis. Our approach is based on Bayesian decision rules to guide interim sample size adjustments. By treating data reliability as a model parameter rather than an external factor, our method accounts for uncertainty and improves the robustness of power calculations.
Simulation studies demonstrate the effectiveness of this strategy. The proposed framework enables a flexible and agile approach to DCT design that can adapt to varying data quality conditions. This work offers a foundation for extending the proposed adaptive method to other trial contexts, including time-to-event endpoints, and supports the broader adoption of DCTs in real-world clinical research.
期刊介绍:
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.